US 10086088
Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord
granted A61KA61K31/7088A61K38/17
Quick answer
US patent 10086088 (Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord) held by The Regents of the University of California expires Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of California
- Grant date
- Tue Oct 02 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 27 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 8
- CPC classes
- A61K, A61K31/7088, A61K38/17, A61K38/177, A61K48/00